Literature DB >> 10763826

The loss of mdm2 induces p53-mediated apoptosis.

S de Rozieres1, R Maya, M Oren, G Lozano.   

Abstract

The p53 tumor suppressor gene product is negatively regulated by the product of its downstream target, mdm2. The deletion of mdm2 in the mouse results in embryonic lethality at 5.5 days post coitum (d.p.c.) which can be overcome by simultaneous loss of the p53 tumor suppressor, substantiating the importance of the negative regulatory function of MDM2 on p53 function in vivo. Hence, the loss of MDM2 allowed the unregulated p53 protein to continuously exert its growth-suppressing activity, which either led to a complete G1 arrest or induced the p53-dependent apoptotic pathway, resulting in the death of the mdm2-/- embryos. To determine which of these possibilities is occurring, mouse embryo fibroblasts (MEFs) from p53 null and p53/mdm2 double null embryos were transfected with a retroviral vector carrying a temperature-sensitive p53 (tsp53) cDNA. Shifting of single-cell clonal populations to the permissive temperature caused the p53-/-mdm2-/- fibroblasts expressing tsp53 to undergo apoptosis in a dose-dependent manner. This phenotype was not observed in the tsp53 expressing p53-/- clones nor the parental cell lines. Thus, our data indicate that the simple loss of mdm2 can induce the p53-dependent apoptotic pathway in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10763826     DOI: 10.1038/sj.onc.1203468

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Knockdown of WWP1 inhibits growth and invasion, but induces apoptosis of osteosarcoma cells.

Authors:  Zhong Wu; Pengfei Zan; Shaohua Li; Jie Liu; Jianguang Wang; Dong Chen; Hua Wang; Yongqiang Qian; Linjie Luo; Xiang Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.

Authors:  Sylvia Hilliard; Karam Aboudehen; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2011-03-21       Impact factor: 3.582

3.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 4.  Transcriptional control of terminal nephron differentiation.

Authors:  Samir S El-Dahr; Karam Aboudehen; Zubaida Saifudeen
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

5.  Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity.

Authors:  Dingding Shi; Wei Gu
Journal:  Genes Cancer       Date:  2012-03

6.  C-terminal ubiquitination of p53 contributes to nuclear export.

Authors:  M A Lohrum; D B Woods; R L Ludwig; E Bálint; K H Vousden
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 7.  20 years studying p53 functions in genetically engineered mice.

Authors:  Lawrence A Donehower; Guillermina Lozano
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

8.  Mdm2 and Mdm4 loss regulates distinct p53 activities.

Authors:  Juan A Barboza; Tomoo Iwakuma; Tamara Terzian; Adel K El-Naggar; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

9.  TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.

Authors:  Shinako Araki; Jacob A Eitel; Christopher N Batuello; Khadijeh Bijangi-Vishehsaraei; Xian-Jin Xie; David Danielpour; Karen E Pollok; David A Boothman; Lindsey D Mayo
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

Review 10.  Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.

Authors:  Ryan S Anderton; Bruno P Meloni; Frank L Mastaglia; Sherif Boulos
Journal:  Mol Neurobiol       Date:  2013-01-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.